Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

The company says around six million people across 60 countries now use its Freestyle Libre glucose monitors which avoid the ...

Libre Rio, by the same company, was approved for people with Type 2 diabetes who do not use insulin. The Abbott options are ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like ...

Combine continuous glucose monitoring data from the FreeStyle Libre 2 system, from wherever you are*, along ... if glucose readings and alarms do not match symptoms or expectations *Sensor is ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

iLet Bionic Pancreas The iLet Bionic Pancreas With the FreeStyle Libre 3 Plus Sensor Beta Bionics' flagship product, the iLet Bionic Pancreas, is an autonomous insulin delivery system that ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.